Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Atherosclerosis”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Not applicableStudy completedNCT00530712
What this trial is testing

Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-popliteal Atherosclerosis

Who this might be right for
Peripheral Vascular DiseasesClaudication
Medtronic Endovascular 287
Not applicableLooking for participantsNCT03291652
What this trial is testing

Morphology of Advanced Symptomatic Cerebral Plaques With High Embolic Potential

Who this might be right for
Ischemic StrokeAtheroscleroses, Cerebral
Chinese University of Hong Kong 140
Not applicableLooking for participantsNCT06315023
What this trial is testing

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Who this might be right for
Peripheral Arterial DiseaseSymptomatic Femoropopliteal Lesions
Endologix 450
Not applicableUnknownNCT03505931
What this trial is testing

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

Who this might be right for
Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)
Yonsei University 100
Not applicableUnknownNCT04305028
What this trial is testing

Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD

Who this might be right for
Peripheral Arterial Disease
Poznan University of Medical Sciences 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT06447701
What this trial is testing

Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

Who this might be right for
Brain DiseasesIschemic StrokeIschemia+4 more
Zhujiang Hospital 486
Not applicableLooking for participantsNCT05757505
What this trial is testing

The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

Who this might be right for
Intracranial Atherosclerosis
Ton-Bridge Medical Tech. Co., Ltd 200
Testing effectiveness (Phase 2)Study completedNCT03060577
What this trial is testing

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

Who this might be right for
Atherosclerotic Cardiovascular DiseaseSymptomatic AtherosclerosisType2 Diabetes+1 more
Novartis Pharmaceuticals 382
Large-scale testing (Phase 3)Looking for participantsNCT04433572
What this trial is testing

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Who this might be right for
Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc. 250
Testing effectiveness (Phase 2)Study completedNCT01645306
What this trial is testing

Revacept in Symptomatic Carotid Stenosis

Who this might be right for
Carotid StenosisAtherosclerosisStroke+3 more
AdvanceCor GmbH 158
Large-scale testing (Phase 3)Study completedNCT02504216
What this trial is testing

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Who this might be right for
Peripheral Artery Disease
Bayer 6,564
Large-scale testing (Phase 3)Looking for participantsNCT07282041
What this trial is testing

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Who this might be right for
Intracranial AtherosclerosisStroke, Ischemic
National University of Singapore 130
Not applicableUnknownNCT02534545
What this trial is testing

Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS)

Who this might be right for
Intracranial Atherosclerosis
Ji Xunming,MD,PhD 3,000
Not applicableLooking for participantsNCT06112171
What this trial is testing

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

Who this might be right for
Peripheral Arterial Disease
University of Leipzig 120
Post-approval studies (Phase 4)WithdrawnNCT04325932
What this trial is testing

Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis

Who this might be right for
Intracranial ArteriosclerosisCollateral CirculationAnterior Cerebral Circulation Infarction
Second Affiliated Hospital, School of Medicine, Zhejiang University
Large-scale testing (Phase 3)Not Yet RecruitingNCT07318610
What this trial is testing

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

Who this might be right for
Peripheral Artery Disease (PAD)
Regeneron Pharmaceuticals 7,050
Testing effectiveness (Phase 2)Study completedNCT01131013
What this trial is testing

CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication

Who this might be right for
Intermittent ClaudicationPeripheral Artery Disease
Cytokinetics 61
Not applicableStudy completedNCT01804088
What this trial is testing

FORMAT Clinical Study

Who this might be right for
Symptomatic Vascular Disease of the Iliac Arteries
Cook Group Incorporated 80
Very early researchEnded earlyNCT03507374
What this trial is testing

PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis

Who this might be right for
StrokeIntracranial AtherosclerosisIntraplaque Hemorrhage
University of Utah 20
Not applicableUnknownNCT03819283
What this trial is testing

NASH and Coronary Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Assistance Publique - Hôpitaux de Paris 260
Load More Results